University of Cincinnati
08/10/2026 | Press release | Distributed by Public on 08/10/2026 13:29
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
2 minute read August 10, 2026 Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Print Story Like
Dr. Sara Medek, an assistant professor of radiation oncology at the UC College of Medicine, is leading a clinical trial to reduce radiation in certain areas while effectively treating cancer with fewer painful side effects.
Medek told Local 12 News for a story that for many people with head and neck cancer, treatment can be as punishing as the disease itself. She is leading a study that focuses on patients with tumors in the oropharynx, the back of the throat, whose cancers are driven by HPV, the human papillomavirus.
Medek is a member of the UC Cancer Center and also a UC Health physician. Her clinical trial is designed to enroll around 30 patients.
"Radiation in the head and neck area has tons of side effects, unfortunately, from getting ulcers inside your mouth or in your throat, in painful areas so that you're not wanting to eat or drink or things like that. We have skin reactions," Medek told Local 12 News.
HPV rarely has symptoms so it can go undetected. Symptoms of HPV-positive head and neck cancer may include a persistent sore throat.
"Often we'll see people who start to notice a lymph node that pops up on their neck, a lump or a bump," adds Medek.
These cancers are typically treated with radiation, but Medek's goal is to decrease the amount of radiation for areas near the tumor to reduce side effects. She says the approach involves reducing the radiation dose in certain lymph node areas while still targeting the tumor.
Listen to the full Local 12 News interview online.
Learn more about Dr. Medek's clinical trial online.
Featured top image of a medical patient provided by iStock.
Tags
Related Stories
1
Cancer Center experts present at national conference
May 27, 2025
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology Annual Meeting May 30 to June 3 in Chicago.
2
US News & World Report: Lung cancer screening and COVID-19
December 21, 2020
New UC research shows a dangerous trend in lung cancer caused by the pandemic.
3
Understanding resistance to targeted therapies in head and neck, breast cancer
July 11, 2025
MSN highlighted University of Cincinnati Cancer Center and Cincinnati Veterans Affairs Medical Center research published in the journal Oncotarget that reviewed current research on why Epidermal Growth Factor Receptor-targeted therapies often fail in breast and head and neck cancers.
University of Cincinnati published this content on August 10, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on August 10, 2026 at 19:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]